What are the non‑surgical treatment options for adenomyosis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: April 12, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Non-Surgical Treatment for Adenomyosis

For symptomatic adenomyosis, start with a levonorgestrel-releasing intrauterine device (progestin IUD) as first-line therapy, which provides superior symptom control compared to combined oral contraceptives and addresses both bleeding and pain. 1

Medical Management Algorithm

First-Line Hormonal Therapy

Progestin IUD (Levonorgestrel-releasing IUD):

  • Most effective first-line option for bleeding and pain control
  • Superior to combined oral contraceptives in randomized controlled trials 1
  • Benefits include: local mechanism of action, minimal systemic hormone exposure, long duration (up to 5 years), and user independence
  • Does NOT address bulk symptoms (uterine enlargement, pressure)

Alternative First-Line Options:

  • Combined oral contraceptives - effective for bleeding and pain, though less effective than progestin IUD 1
  • GnRH antagonist combinations - pooled analysis of 2 RCTs shows effectiveness for heavy menstrual bleeding even with concomitant adenomyosis 1

Non-Hormonal Adjuncts

  • NSAIDs - for pain control and bleeding reduction 1
  • Tranexamic acid - nonhormonal option specifically for bleeding symptoms 1

Minimally Invasive Procedural Options (When Medical Therapy Fails)

Uterine Artery Embolization (UAE)

Use UAE when:

  • Medical management fails
  • Patient desires uterus preservation
  • Not actively seeking pregnancy

Evidence for UAE:

  • Meta-analysis shows 94% short-term (<12 months) and 85% long-term (>12 months) symptom improvement 1
  • 7-18% eventually require hysterectomy for persistent symptoms 1, 2
  • Up to 7-year follow-up data shows sustained quality of life improvement 1, 2
  • Symptom control ranges 73-88% in recent studies with median follow-up 24-65 months 2

Important Caveats:

  • Limited fertility data - counsel patients accordingly 1
  • More effective when fibroids predominate over pure adenomyosis 1
  • Ongoing QUESTA trial comparing UAE to hysterectomy outcomes 1

Critical Treatment Limitations

What Medical Therapy CANNOT Do:

  • Hormonal treatments (progestin IUD, oral contraceptives, GnRH antagonists) will NOT treat bulk symptoms like uterine enlargement or pressure effects 1
  • If bulk symptoms are the primary complaint, consider UAE or surgical options

Fertility Considerations:

  • For women desiring pregnancy, comprehensive fertility data after UAE is lacking 1
  • GnRH analogues may be used before fertility treatments to improve pregnancy chances 3
  • Successful pregnancies reported after UAE but with limited data 1

Treatment Selection Framework

  1. Bleeding and/or pain WITHOUT bulk symptoms → Progestin IUD first-line
  2. Bleeding and/or pain WITH bulk symptoms → Consider UAE after failed medical therapy
  3. Failed medical therapy + desire for uterus preservation → UAE (expect 85-94% symptom improvement)
  4. Seeking fertility → GnRH analogues before fertility treatment; avoid UAE as first choice

Common Pitfalls to Avoid

  • Don't use myomectomy alone - adenomyosis is diffuse and unlikely to be effectively addressed by focal excision 1
  • Don't expect hormonal therapy to shrink the uterus - these medications control symptoms but don't address bulk
  • Don't overlook coexisting conditions - adenomyosis frequently coexists with fibroids and endometriosis, which may alter treatment approach 2
  • Don't promise cure with medical therapy - no current drug can cure adenomyosis; treatment is symptom management 4, 3

The evidence strongly supports a stepwise approach: medical management first (progestin IUD preferred), then UAE for failures desiring uterus preservation, with hysterectomy reserved for definitive treatment when fertility is not desired and other options have failed.

References

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.